Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

A influência da lateralização cortical no controle motor seletivo do balanço do braço durante a caminhada independente após acidente vascular cerebral.

16 de setembro de 2026 atualizado por: University Hospital, Ghent

The upper limbs play an essential role for safe and efficient walking in healthy persons and persons post-stroke. Nevertheless, in current post-stroke gait rehabilitation (research) the upper limbs are barely targeted. To address this gap, my project aims to investigate the selective motor control of the upper limbs during walking and the contribution of the cortical activity to the arm swing in independent walkers after stroke.

To gain insight in the direct effects of stroke on the arm swing, the primary motor control of the arm swing will be evaluated by determining muscle synergies (i.e group of muscles working together as a task-specific functional unit). Additionally, the cortical activity (EEG-analysis) during walking of persons post-stroke will be compared to healthy controls and the relationship between stroke-induced changes in cortical activity and arm swing deviations will be assessed. Furthermore, I will evaluate whether improvements in cortical activity relate to improvements in primary motor control of the arm swing.

This innovative project will be the first to investigate the direct coupling between the cortex and the muscle synergies in persons post-stroke during independent walking to investigate the arm swing. These fundamental insights in the primary motor control of the arm swing and the contribution of the cortical activity will allow to develop targeted interventions aiming to improve arm swing and as such optimize post-stroke gait rehabilitation.

Research questions:

  1. How can muscle synergies explain arm swing alterations in independent walkers after stroke?
  2. How do stroke-induced changes in cortical activity relate to arm swing deviations in persons after stroke?
  3. Are changes in primary motor control of the upper limb during walking related to normalization of brain activity in independent walkers after stroke?

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

84

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

      • Diepenbeek, Bélgica, 3590
        • Recrutamento
        • UHasselt - Faculteit Revalidatiewetenschappen
        • Contato:
        • Contato:
    • Oost-Vlaanderen
      • Ghent, Oost-Vlaanderen, Bélgica
        • Recrutamento
        • Ghent University Hospital
        • Investigador principal:
          • Arne Defour, Msc.
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 70 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Stroke

Inclusion Criteria:

  • First-ever and cerebral stroke
  • Able to walk at least 10 minutes (FAC ≥ 3)
  • Presence of upper limb paresis (NIHSS item 5a/b > 0)

Exclusion Criteria:

  • Other neurological disorders

Healthy controls

Inclusion criteria:

  • Older than 18 years
  • Able to walk at least 10 minutes

Exlusion criteria:

  • Pregnancy

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Não randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Stroke

Persons with a unilateral first ever stroke

Participants have to walk without holding handrails and without bodyweight support for at least 200 gait cycles. They are asked to walk at comfortable walking speed while watching forward to a screen without virtual reality projection. Arm should be next to the body to allow arm swing if possible.

Comparador Ativo: Control

Age and gender matched healthy controls

Participants have to walk without holding handrails and without bodyweight support for at least 200 gait cycles. They are asked to walk at comfortable walking speed while watching forward to a screen without virtual reality projection. Arm should be next to the body to allow arm swing if possible.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Number of muscle synergies
Prazo: Single point of assessment at inclusion

The number of muscle synergies needed to account for 90% variance in muscle activity measured by surface EMG during walking in stroke survivors compared to healthy controls. Following muscles will be examined:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment at inclusion
Number of muscle synergies
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

The number of muscle synergies needed to account for 90% variance in muscle activity measured by surface EMG during walking in stroke survivors after a follow-up period of three months. Following muscles will be examined:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment 3 months after inclusion (only for stroke survivors)
Weight of muscle synergies
Prazo: Single point of assessment at inclusion

The number or distribution of muscle weightings within a synergy during walking in stroke survivors compared to healthy controls.

The distribution of muscle activation averages over one gait cycle measured by surface EMG of following muscles:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment at inclusion
Weight of muscle synergies
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

The number or distribution of muscle weightings within a synergy during walking in stroke survivors after a follow-up period of three months.

The distribution of muscle activation averages over one gait cycle measured by surface EMG of following muscles:

  • tibialis anterior,
  • gastrocnemius lateralis
  • soleus
  • vastus medialis
  • vastus lateralis
  • rectus femoris
  • biceps femoris
  • gluteus medius
  • erector spinae
  • latissimus dorsi
  • anterior deltoid
  • posterior deltoid
  • biceps brachii
  • triceps brachii
Single point of assessment 3 months after inclusion (only for stroke survivors)
Brain symmetry index (BSI)
Prazo: Single point of assessment at inclusion

The amount of cortical lateralization during walking in stroke survivors compared to healthy controls. The score ranges from -1 to +1 with BSI = 0 reprenting perfect symmetry. Positive values represent higher power in the right hemishere compared to the left hemisphere, vice versa for negative values. For left side lesions, BSI was multiplied by -1.

Single point of assessment at inclusion
Brain symmetry index (BSI)
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

The amount of cortical lateralization during walking in stroke survivors after a follow-up period of three months. The score ranges from -1 to +1 with BSI = 0 reprenting perfect symmetry. Positive values represent higher power in the right hemishere compared to the left hemisphere, vice versa for negative values. For left side lesions, BSI was multiplied by -1.

Single point of assessment 3 months after inclusion (only for stroke survivors)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Upper limb kinematics
Prazo: Single point of assessment at inclusion

Movements of the upper limb during walking measured by 3D kinematics and expressed as angles (°)

Single point of assessment at inclusion
Upper limb kinematics
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

Movements of the upper limb during walking measured by 3D kinematics and expressed as angles (°)

Single point of assessment 3 months after inclusion (only for stroke survivors)
Cortico-synergy coherence
Prazo: Single point of assessment at inclusion

The amount of coherence (i.e. phase locking) between the muscle synergies and cortical activity during walking in stroke survivors compared to healthy controls. Higher values (0-1) indicate a better linear association.

Single point of assessment at inclusion
Cortico-synergy coherence
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

The amount of coherence (i.e phase locking) between the muscle synergies and cortical activity during walking in stroke survivors after a follow-up period of three months. Higher values (0-1) indicate a better linear association.

Single point of assessment 3 months after inclusion (only for stroke survivors)

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
National Institutes of Health Stroke Scale (NIHSS)
Prazo: Single point of assessment at inclusion (only for stroke survivors)

Quantifies the impairment caused by a stroke. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The highest score is 42.

Single point of assessment at inclusion (only for stroke survivors)
National Institutes of Health Stroke Scale (NIHSS)
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

Quantifies the general impairment caused by a stroke after a follow-up period of three months. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The highest score is 42.

Single point of assessment 3 months after inclusion (only for stroke survivors)
Fugl-Meyer assesment - Upper limbs
Prazo: Single point of assessment at inclusion (only for stroke survivors)

Assesses specifc motor impairments of the upper limbs of stroke survivors. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment at inclusion (only for stroke survivors)
Fugl-Meyer assesment - Upper limbs
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

Assesses specifc motor impairments of the upper limbs of stroke survivors after a follow-up period of three months. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment 3 months after inclusion (only for stroke survivors)
Tardieu scale
Prazo: Single point of assessment at inclusion (only for stroke survivors)

Quantifies spasticity by assessing the muscle's response (0-5) to different stretch velocities (V1, V2 or V3) and by determining the spasticity angle (R1 or R2).

Single point of assessment at inclusion (only for stroke survivors)
Tardieu scale
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

Quantifies spasticity by assessing the muscle's response (0-5) to different stretch velocities (V1, V2 or V3) and by determining the spasticity angle (R1 or R2).

Single point of assessment 3 months after inclusion (only for stroke survivors)
10 Meter Walking Test
Prazo: Single point of assessment at inclusion (only for stroke survivors)

Examins the walking capacity of a stroke survivor by measuring how long it takes to walk a distance of 10 meters (in seconds).

Single point of assessment at inclusion (only for stroke survivors)
10 Meter Walking Test
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

Examins the walking capacity of a stroke survivor by measuring how long it takes to walk a distance of 10 meters (in seconds).

Single point of assessment 3 months after inclusion (only for stroke survivors)
Fugl-Meyer assesment - Lower limbs
Prazo: Single point of assessment at inclusion (only for stroke survivors)

Assesses specifc motor impairments of the lower limbs of stroke survivors. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment at inclusion (only for stroke survivors)
Fugl-Meyer assesment - Lower limbs
Prazo: Single point of assessment 3 months after inclusion (only for stroke survivors)

Assesses specifc motor impairments of the lower limbs of stroke survivors after a follow-up period of three months. The Fugl-Meyer Assessment scale is an ordinal scale that has 3 points for each item. A zero score is given for the item if the subject cannot do the task. A score of 1 is given when the task is performed partially and a score of 2 is given when the task is performed fully. However, reflex activity is measured using 2 points only, with a score of 0 or 2 for absence and presence of reflex respectively.

Single point of assessment 3 months after inclusion (only for stroke survivors)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Anke Van Bladel, PhD, Ghent University and Ghent University Hospital

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

9 de julho de 2024

Conclusão Primária (Estimado)

30 de dezembro de 2026

Conclusão do estudo (Estimado)

30 de setembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

29 de maio de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

29 de maio de 2024

Primeira postagem (Real)

4 de junho de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

21 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • ONZ-2024-0089
  • 11PEU24N (Número de outro subsídio/financiamento: FWO)

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .